Partners & Clinical Platforms
Baylor Genetics, an affiliate of the #1 NIH-funded genetics program at Baylor College of Medicine, has been a pioneer of precision medicine for nearly 40 years.
Today, we offer a full spectrum of cost-effective genetic testing providing clinically relevant solutions. Our unmatched experience delivers a combination of advanced technology, deep patient data sets, and genetic talent that leads accurate interpretations of the most complex cases.
The clinical utility of our tests and the care we take to educate providers and patients is in our DNA. We’re complemented by the entire Baylor College of Medicine staff of medical geneticists, faculty, genetic counselors, and researchers who help us drive discoveries and testing. By bridging academic and operational excellence, Baylor Genetics offers the medical community an extensive testing menu, access to world-renowned experts, and the confidence to provide patients with answers.
Baylor Genetics, located in Houston’s Texas Medical Center, serves clients in 50 states and 16 countries. Connect with us via our website (bmgl.com), Twitter (@baylorgenetics), Facebook (facebook.com/baylorgenetics), or LinkedIn (linkedin.com/company/baylorgenetics).
Adult Exome Screening Test
Cancer Exome Sequencing Test
OneOme was established by Invenshure and Mayo Clinic to provide a comprehensive, cost-effective pharmacogenomic solution integrated into patients’ everyday clinical care.
OneOme’s key product offering is the RightMed® pharmacogenomic test, a physician-ordered genetic test that predicts how a patient’s DNA and current prescriptions may affect their response to medications.
The analysis is provided to the physician in the form of static and interactive reports that identifies which prescription drugs are — or aren’t — likely to work.
This information can help providers make better prescription decisions, protect patients from adverse drug reactions and drug ineffectiveness, and reduce healthcare costs.
Our mission is to deliver the most cost-effective, comprehensive, clinically actionable pharmacogenomic (PGx) testing and tools for all providers and patients worldwide.
OneOme RightMed Pharmacogenomic Test
Color is a modern health service that applies expertise in robotics, genomics, software and design to a crucial healthcare challenge: preventing or detecting conditions where early knowledge can improve health outcomes and reduce treatment costs.
Color's affordable, clinical-grade genetic tests help people understand their risk for hereditary cancer and heart conditions - knowledge that they and their doctors can use to create personalized health plans.
Rainbow provides Color’s hereditary cancer and heart health tests with localized genetic counseling and translated clinical reports, supporting both patients and their physicians.
Our "preferred" partnership with Color enables us to provide affordable hereditary cancer and heart health tests to middle class patients who otherwise could not afford to be tested.
Color Hereditary Cancer Test
Color Hereditary Heart Health Test
Fabric Genomics is making precision medicine a reality by facilitating clinical labs, hospital systems, and country-sequencing programs to develop, deploy, and scale genomic testing.
Our AI approach to genome interpretation, and SOP-based workflows enable rapid generation of physician-ready clinical reports for any genomic test.
Our tools enable scientists to quickly and accurately process and analyze whole genomes, exomes and gene panels. Fabric Genomics’ cutting-edge genomic data processing and advanced algorithmic tools have been licensed by over 1,000 academic institutions and clinical laboratories around the world.
Fabric Genomics’ core customers are commercial clinical laboratories, hospital core labs, country sequencing programs, and research institutions.
Pediatric Exome Sequencing - Health Screening & Diagnostic Test*
Pediatric Whole Genome Sequencing - Health Screening & Diagnostic Test*
Adult Exome Sequencing Diagnostic Test*
*Double interpretation with the Center for Intractable Disease Research - Juntendo University Medical School
Macrogen is a precision medical and biotechnology company with a global reach.
Established on June 5, 1997 from the Genome Medical Research Institute of Seoul National University, Macrogen became Korea’s first bio venture company listed on KOSDAQ in February 2000.
Its commercialization of technologies and ongoing research and development have earned it the distinguished reputation as Korea’s leading biotechnology company and a global genetic analysis specialist.
Macrogen has about 18,000 lab customers in 153 countries. Macrogen is making a positive impact on the local community by being a socially responsible neighbor that performs ongoing R&D and social contributive activities.
Clinical diagnostics and personal genome studies are an integral part of precision medicine and that are where Macrogen makes large investments and performs research and development. Macrogen is involved in genome testing for cancer, antepartum, and rare diseases, and personal genome testing to provide customized diagnostics, treatment, and care.
Macrogen uses US-based Illumina genotyping platform, a gold standard in genotyping content and accuracy.
Macrogen Common Disease Risk Assessment Test
Macrogen Personal Health Assessment Test
Juntendo University Medical School
The mission of Juntendo University is to strive for advances in society through education, research, and healthcare.
Juntendo was originally founded in 1838 as a Dutch School of Medicine at a time when Western medical education was not yet embedded as a normal part of Japanese society. Through the years the institution’s experience and perspective as an institution of higher education and a place of clinical practice has enabled Juntendo University to play an integral role in the shaping of Japanese medical education and practices.
Rainbow partners with Juntendo’s clinical and genomic medicine teams at the Center of Intractable Disease Research,
The Juntendo medical team has many years of experience providing genetic testing to Asian patients. More importantly, the Japanese bioinformaticians and clinicians are trained to provide clinical interpretation specifically for Asian patients including Chinese and Japanese individuals.
Double Clinical Interpretation Services
Pediatric Exome/Whole Genome Health Screening and Diagnostic Tests (with Fabric Genomics)
Adult Exome Diagnostic Tests (with Fabric Genomics)
Pathway OME is the leading genetic wellness company for Nutrition, Exercise, Skincare and Artificial Intelligence (AI), used to help guide lifestyle, diet and nutritional supplement decisions to improve the overall health and well-being of patients.
Since its founding in 2009, Pathway Genomics has become known for its dedication to innovation – making it a leader in the commercial personalized health and wellness industries.
Focusing on providing users with the most validated and personalized healthcare information delivered to any device, the company’s program with IBM data is the first of its kind to merge artificial intelligence (AI) and deep learning with precision medicine, applicable to both consumers and providers.
Pathway SkinFit and SkinIQ Tests
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management.
Quest Diagnostics is the world’s leading provider of diagnostic information services
Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
Generated 2017 revenues of approximately US$7.7 billion
Publicly trades common stock on the New York Stock Exchange (NYSE: DGX). More in Investor Relations. Ranks as a component of the S&P 500
Serves about half of the physicians and hospitals in the U.S
Engages workforce of about 45,000 employees dedicated to putting patients first every day
Operates more than 2,200 patient service centers
A medical and scientific staff of more than 650 M.D.s and Ph.D.s
Logistics capabilities, that include approximately 3,700 courier vehicles and 23 aircraft that collectively make tens of thousands of stops daily
Baylor College of Medicine
As a product of the Department of Molecular and Human Genetics at Baylor College of Medicine in collaboration with Baylor Genetics, Consultagene leverages the intellectual capital of the department's faculty, 180 members strong, and healthcare providers.
This group includes the following:
25 clinical & medical biochemical geneticists with expertise in adult, prenatal, and pediatric genetics, neurogenetics, cardiovascular, cancer and metabolic genetics, skeletal dysplasias, and connective tissue and mitochondrial disorders
Education. Access educational videos, pamphlets, and web-based resources that are personally selected by experts to fit your situation and your genetic health concerns.
Genetic Counseling. In-depth counseling with one of our certified genetic counselors through our secure, self-scheduled portal to answer your genetic health questions and to connect you with the next steps.